Advanced Transit Dynamics News

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.

The Wharton School, through its Initiative for Global Environmental Leadership, partnered with Johnson & Johnson to convene healthcare professionals and share best practices for measuring the value of sustainability initiatives.

Clinical trials conducted by Janssen Research & Development, LLC points to evidence that its experimental drug, siltuximab improved symptoms and shrank growths in patients with Castleman disease, a rare blood disorder that causes enlarged lymph nodes.

Although relatively small in size, the two companies' brand lineups are robust. As such, Church & Dwight and Prestige Brands represent two of the most well-rounded investments in the space.

Sovaldi is approved to treat four different strains of hepatitis virus referred to as genotype 1-4.

This week's multi-billion dollar corporate bond offerings from Microsoft, CVS Caremark and Johnson & Johnson pushed the volume of US non-financial investment grade corporate debt to $438.0 billion for year-to-date 2013, a 6% increase compared to a year ago and the strongest year-to-date period on record.

The firm currently has a $61.00 target price on the stock, up from their previous target price of $45.00.

Janis Plostnieks, 80, of Blue Bell, a corporate chemist and executive at Johnson & Johnson for many years, died Friday, Nov. 29, of cancer at Holy Redeemer Hospital.

Johnson & Johnson officials destroyed or misplaced documents related to its vaginal-mesh implants and should be barred from relying on some defenses in planned trials over the devices, patients' lawyers said.

Johnson & Johnson and Bayer's drug Xarelto generated $246 million in sales in the third quarter, while sales of Eliquis from Pfizer and Bristol-Myers Squibb were $41 million for the same period.

Johnson & Johnson, the AAA rated maker of health-care products from Band-Aids to Listerine, sold $3.5 billion of bonds in its first offering since 2011.

Under a recent settlement, medical insurers may receive $1 billion from Johnson & Johnson for covering the cost of removing recalled hip implants.

However, over the past year, shares of the diversified medical giant have climbed 34% -- outperforming both the market and most of its big-pharma industry peers.

Johnson & Johnson companies are equal opportunity employers. Territory Manager - Boston, MA - Biosense Webster, Inc.-5885130715 Description Biosense Webster, a member of Johnson & Johnson's Family of Companies, is recruiting for a Territory Manager, to cover the Boston, MA territory.

Same with stocks. The great ones don't stay great forever. Look at Microsoft , Johnson & Johnson , Merck , Cisco , General Electric .

TORONTO , Nov. 25, 2013 /CNW/ - MaRS Innovation , a Centre of Excellence for Commercialization and Research, today announced a new collaboration with Johnson & Johnson Innovation and its affiliate Janssen, Inc. , in Canada to advance early-stage technologies related to human health in therapeutics, medical devices, and diagnostics.

GMO, the $112 billion investment management firm led by chief investment strategist Jeremy Grantham is out with its latest quarterly letter and the news remains the same: stocks, in general, are not at all compelling.

MARK COLVIN: Hundreds of women have joined a class action against the medical giant Johnson and Johnson over a range of their products.

After decades of Hepatitis C claims that there is no viable treatment, other than the regularly prescribed antiviral medication, Johnson and Johnson has come up with a drug to inhibit and eliminate Hep C altogether.

The U.S. Food and Drug Administration said Friday it approved the drug, a protease inhibitor that blocks a protein needed by the virus to replicate.